M. Raffini

Safety profile and impact on survival of tyrosine kinase inhibitors versus conventional therapy in relapse or refractory FLT3 positive acute myeloid leukemia patients.

S. Paolini, G. Martinelli, E. Ottaviani, 2020, Leukemia research.

Aggressive Aneuploid Acute Myeloid Leukemia Is Dependent on Alterations of P53, Gain of APC and PLK1 and Loss of RAD50

T. Haferlach, G. Martinelli, M. Delledonne, 2016 .

Identification of Two DNMT3A Mutations Compromising Protein Stability and Methylation Capacity in Acute Myeloid Leukemia

G. Martinelli, E. Ottaviani, G. Simonetti, 2019, Journal of oncology.